<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR1800015944</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2018-05-02</date_registration>
      <primary_sponsor>The First Affiliated Hospital of Guangxi Medical University</primary_sponsor>
      <public_title>Autologous Bone Marrow-derived Mesenchymal Stem Cells (BMSCs) Transplantation for ovarian function recovery on Premature Ovarian Insufficiency (POI) patients</public_title>
      <acronym />
      <scientific_title>Autologous Bone Marrow-derived Mesenchymal Stem Cells (BMSCs) Transplantation for ovarian function recovery on Premature Ovarian Insufficiency (POI) patients</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2018-05-01</date_enrolment>
      <type_enrolment />
      <target_size>Case series:20;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=24858</url>
      <study_type>Observational study</study_type>
      <study_design>Before-After control</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext> Premature Ovarian Insufficiency</hc_freetext>
      <i_freetext>Case series:Single side ovary injection of   autologous BMSCs;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Yihua Yang</firstname>
        <middlename />
        <lastname />
        <address>6 Shuangyong Road, Qingxiu District, Nanning, Guangxi Zhuang Autonomous Region, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15007737358</telephone>
        <email>workyyh@163.com</email>
        <affiliation>The First Affiliated Hospital of Guangxi Medical University</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Aiping Qin</firstname>
        <middlename />
        <lastname />
        <address>NO.6 Shuangyong Road, Qingxiu District, Nanning, Guangxi Zhuang Autonomous Region, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 13977102456</telephone>
        <email>aipingqin@gmail.com</email>
        <affiliation>The First Affiliated Hospital of Guangxi Medical University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Female aged between 18-40 years old; 
2. Menorrhea or oligomenorrhea at least for 3-6 months;
3. FSH level above 25 IU/L (repeated twice &gt;4 weeks apart);
4. Presence of  bilateral ovary;
5. No combined with male infertility;
6. Normal karyotype 46, XX;
7. Normal prolactin level within one year of study initiation;
8. Normal thyroid function as evidence by normal serum TSH levels;
9. Willing to attempt to get pregnant as part of the experimental protocol.Agree to report any pregnancy to the research staff immediately;
10.Willing and able to comply with study requirements.</inclusion_criteria>
      <agemin>18</agemin>
      <agemax>40</agemax>
      <gender>Female</gender>
      <exclusion_criteria>1. History of gynecologic malignancy and pelvic surgery;
2. Contraindication to surgery or anesthesia;
3. Combined with major physical illnesses or  mental disorders, such as heart diseases, Type I or Type II diabetes mellitus, significant anemia that precludes performance of surgery;</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Resumption of Menses;Improvement in hormone levels (FSH, LH, E2, P, Anti-Mullerian Hormone);Number of mature follicle;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Occurrence of pregnancy;Endometrium thickness;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Scientific research funding and hospital funding</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-01-30</approval_date>
        <contact_name>Feng Huang</contact_name>
        <contact_address>6 Shuangyong Road, Qingxiu District, Nanning, Guangxi Zhuang Autonomous Region, China</contact_address>
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>